Showing results (501-510 of 1,658) with videos related to
Sort By:
Pageof 166
Journal of Thrombosis and Haemostasis : JTH|October 10, 2007
Development of sandwich-type ELISAs for the quantification of rat and murine thrombin activatable fibrinolysis inhibitor in plasmaK Hillmayer, E Brouwers, F León-Tamariz, et al.Thrombosis and Haemostasis|November 1, 2001
The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentrationL O Mosnier, T Lisman, H M van den Berg, et al.Nano Letters|May 12, 2005
Size-dependent photoconductivity in MBE-grown GaN-nanowiresRaffaella Calarco, Michel Marso, Thomas Richter, et al.Agents and Actions|January 1, 1993
Cysteine proteinase activity in the development of arthritis in an adjuvant model of the ratM H Meijers, J Koopdonk-Kool, S C Meacock, et al.Tijdschrift Voor Gerontologie En Geriatrie|November 23, 2013
[Basic care in nursing homes: longitudinal presentation of care problems measured with the National Prevalence Measurement of Care Problems (LPZ)]R J G Halfens, E Meesterberends, J M M Meijers, et al.British Journal of Haematology|July 30, 2013
Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patientsKamran Bakhtiari, Pieter W Kamphuisen, Maria E Mancuso, et al.Nederlands Tijdschrift Voor Geneeskunde|September 23, 2017
[DNA diagnostics in dementia]C M Aalfs, R Vervenne-van Spaendonk, Y A L Pijnenburg, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 15, 2018
Poor Vitamin K Status Is Associated With Low Bone Mineral Density and Increased Fracture Risk in End-Stage Renal DiseasePieter Evenepoel, Kathleen Claes, Bjorn Meijers, et al.Journal of Thrombosis and Haemostasis : JTH|November 25, 2003
Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinuxT Lisman, N R Bijsterveld, J Adelmeijer, et al.Diabetes Care|January 30, 2004
Anti-inflammatory and anticoagulant effects of pravastatin in patients with type 2 diabetesDirkje W Sommeijer, Melvin R MacGillavry, Joost C M Meijers, et al.Pageof 166